Notably, although we have demonstrated that VDAC2 is a glycolytic regulator and involves in controlling the phenotype transition between GSCs and NSTCs, the molecular mechanisms of how glycolytic changes regulate the stemness of glioma cells need to be further explored. The gene discussed is VDAC2; the disease is central nervous system cancer.